Antigenic determinants of influenza virus hemagglutinin XII. The epitopes of a synthetic peptide representing the C-terminus of HA1
References (17)
- et al.
Immunogenic structure of the influenza virus hemagglutinin
Cell
(1982) - et al.
Influenza viruses cause hemolysis and fusion of cells
Virology
(1981) - et al.
Antigenic determinants of influenza virus hemagglutinin. XI. Conformational changes detected by monoclonal antibodies
Virology
(1985) - et al.
Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites
Mol. Immunol.
(1985) - et al.
Sequence of the hemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterised monoclonal antibody-derived variants
Virology
(1983) - et al.
- et al.
Crystalline antigen from the influenza virus envelope
Nature New Biol
(1972) - et al.
A novel approach to automated peptide synthesis based on new insights into solid phase chemistry
Cited by (34)
Single dose intranasal immunization with ISCOMATRIX™ vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract
2009, VaccineCitation Excerpt :Lung and nasal washes were centrifuged at 4 °C at 6000 rpm for 5 min and the resulting supernatants pooled and concentrated 4-fold using 30,000 MW cut-off Centricon filter devices (Millipore, Bedford, MA, USA) prior to assay by ELISA. ELISA was used for the measurement of virus-specific antibodies in sera, saliva, BAL or vaginal and nasal washings as previously described [36], using 96-well flat-bottomed polyvinyl microtiter plates (Dynatech Laboratories, Australia) coated with 5 μg/mL protein/well of purified split MEM71 virus. To assess the isotype profile of antibodies, an ELISA was undertaken using rabbit anti-mouse antibodies directly conjugated to HRP and specific for the different isotypes IgM, IgA, IgG1, IgG2a, IgG2b and IgG3 (Southern Biotech, Birmingham, AL).
A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
2009, VaccineCitation Excerpt :Sera were collected and stored at −20 °C until analysis. The titer of immunogen-specific antibodies were quantified by ELISA, as previously described [22]. Avidity ELISA was carried out using previously described method [23].
Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination
2008, VaccineCitation Excerpt :PR8 virus for immunization or challenge (50 pfu in 30 μl PBS) was administered intranasally (i.n.) under penthrane-induced anesthesia. ELISA was performed based on a previously described method [26]. Each well of 96-well polyvinyl microtiter trays (Dynatech Laboratories) was coated with 50 μl of PBS containing purified inactivated PR8 virus (5 μg total protein/ml).
- 2
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria 3052, Australia.